ACCESS Newswire

DQLabs, Inc.

Share
DQLabs Modern Data Quality Summit 2024 Accelerates Path to AI-Readiness

Quality Data, Smart AI - You are as AI-Ready as Your Data

PASADENA, CA / ACCESSWIRE / August 13, 2024 / DQLabs, the Modern Data Quality and Observability company is hosting the Modern Data Quality Summit (MDQS) 2024. This exclusive event will empower attendees, from business leaders to technologists, to get their Data AI-Ready for their enterprise to be AI-Ready. Register now.

To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.
Modern Data Quality Summit

About MDQS 2024

This year's summit, themed "Quality Data for Smart AI," aims to address the critical intersection of data quality, AI readiness, and governance. With the rapid advancement of AI technologies, ensuring high-quality data has never been more crucial. MDQS 2024 will offer a unique platform for attendees to learn from the best in the industry and gain insights into leveraging data for AI-driven decision-making and innovation.

Why Attend MDQS 2024?

Here are the top five reasons why you should mark your calendar for MDQS 2024:

  1. Expert-Led Sessions: With over 12+ deep-dive sessions led by industry visionaries like Bill Inmon, Sanjeev Mohan, Wayne Eckerson, Bruno Aziza, Prashanth Southekal, Juan Sequeda and others, attendees will gain insights into the latest developments in the data and AI industry.

  2. Thought-Provoking Content: Learn about the latest trends in Data Quality, Data Observability, Data Products, Data Governance, Metadata, AI Strategy and innovative solutions that can help you leverage data for your ambitious AI projects. The summit will cover a wide range of topics from the Data and AI world.

  3. Inspiring Keynotes: Hear from thought leaders shaping the future of data quality and AI. Gain valuable, actionable insights to drive your organization's data initiatives forward.

  4. Flexible Participation: You can join us from anywhere - virtually, at no cost! Attending MDQS 2024 can benefit your organization by bringing back insights and ideas to transform your Data & Analytics strategy, programs, and initiatives.

  5. Exciting Networking Opportunities: Connect with Data & AI leaders from Fortune 500 companies and build lasting professional relationships.

Featured Speakers

MDQS 2024 has a stellar lineup of speakers who are renowned for their expertise and contributions to the data industry. Some of the notable speakers include:

  • Bill Inmon: Known as the "Father of Data Warehouse," Bill Inmon will share his vast knowledge and experience in unstructured data and textual analytics.

  • Sanjeev Mohan: A leading figure in data analytics, Sanjeev Mohan will provide insights into data governance and AI's impact on data quality.

  • Wayne Eckerson: An international thought leader in data and analytics, Wayne Eckerson will discuss the evolution of data quality, data products with a focus on AI.

  • Bruno Aziza: With a track record of scaling high-growth technology companies, Bruno Aziza will delve into the importance of data quality for AI-driven decision-making.

Registration Information

Don't miss out on this opportunity to stay ahead in the data and AI industry. Seats are filling fast, register now to secure your spot at MDQS 2024.

Visit Modern Data Quality Summit for more information and to register.

Contact Information

DQLabs PR
pr@dqlabs.ai
7203600686

SOURCE: DQLabs, Inc.

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release

MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye

IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release

Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres

General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release

DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG

OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper

Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release

VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye